News
Media
Conferences
Publication
Resources
Subscribe
Educator of the Year

|Articles|September 1, 2004

Chiron Acquires Prion Solutions Inc.

EMERYVILLE, Calif. -- Chiron Corporation announced that it had acquired Prion Solutions Inc., a privately held company based in La Jolla, Calif., focused on research into variant Creutzfeldt-Jakob disease (vCJD) and other prion-related diseases. Financial terms of the acquisition were not disclosed.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Related Content

Hospital cafeteria (Gemeni AI-generated image by author)

What Are the Infection Prevention Risks in the Hospital Tray Line?

ByDonald Sipp, MBA, RESE, CHESP, CHTI-2, CMIP, PMP

November 4th 2025

AI-generated image of 2 women friends, a man in a wheelchair, and a brown dog. (ChatGPT AI image)

Editor's Letter: Tim and Monica's Story About Sepsis, Survival, and the Strength to Keep Going

ByTori Whitacre Martonicz

November 3rd 2025

in data from 1 study, a cocktail of 4 bacteriophages against an infection demonstrated approximately 50% activity against a broad spectrum of bacterial strains, indicating that the bacteriophage cocktail killed 50% of the strains. Once a bacterial phage of recombinant type was added to this cocktail, that activity increased to 71%

Multidrug-Resistant Infections Necessitate Bacteriophage Treatment: Can We Get There in Time?

ByEdward “Ted” Wright, Jr, PhD

November 3rd 2025

Veteran Infection Preventionists Chat: What Are the Soft Skills That Make Strong IPs?

ByTori Whitacre Martonicz

November 1st 2025

Yellow highway sign for H5N1 or the bird flu (Adobe Stock 838709294 by Rex Wholster)

Beyond the Barnyard: How H5N1 Is Crossing Species—and Borders

ByKevin Kavanagh, MD

October 31st 2025

Latest CME

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Trending on Infection Control Today

Multidrug-Resistant Infections Necessitate Bacteriophage Treatment: Can We Get There in Time?

Editor's Letter: Tim and Monica's Story About Sepsis, Survival, and the Strength to Keep Going

What Are the Infection Prevention Risks in the Hospital Tray Line?

© 2025 MJH Life Sciences^®

All rights reserved.